Mackenzie Financial’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-44,336
Closed -$1.02M 1814
2025
Q2
$1.02M Sell
44,336
-1,783
-4% -$41.3K ﹤0.01% 1007
2025
Q1
$1.04M Sell
46,119
-26,272
-36% -$610K ﹤0.01% 968
2024
Q4
$1.42M Buy
72,391
+33,728
+87% +$668K ﹤0.01% 860
2024
Q3
$704K Buy
+38,663
New +$738K ﹤0.01% 944
2022
Q4
Sell
-27,135
Closed -$924K 1553
2022
Q3
$924K Buy
+27,135
New +$1M ﹤0.01% 831

Other funds holding PRVA

Mackenzie Financial's PRVA Position: Q3 2025 in Review

Mackenzie Financial sold out of Privia Health (PRVA) in Q3 2025, closing a stake of 44,336 shares — an estimated $1.02M sold.

Mackenzie Financial first reported a position in PRVA in Q3 2022 and held it in 5 quarters. The position peaked at $1.42M in Q4 2024. 259 funds tracked by Wall St. Rank hold PRVA as of Q3 2025.

  • Mackenzie Financial reported no remaining Privia Health position as of Q3 2025 after selling out during the quarter.
  • Mackenzie Financial sold 44,336 Privia Health shares in Q3 2025, an estimated $1.02M.
  • Mackenzie Financial first reported a position in Privia Health in Q3 2022 and held it in 5 quarters.
  • Mackenzie Financial's Privia Health position peaked at $1.42M in Q4 2024.
  • 259 funds tracked by Wall St. Rank held Privia Health as of Q3 2025.

Based on Mackenzie Financial's 13F filing for Q3 2025, filed 13 Nov 2025.